Advertisements


Pharma, Biotech Bull ETFs Leading the Charge

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsJul 12th, 2018

Walmart leading the retail charge against Amazon?

Amplify ETFS CEO Christian Magoon on the outlook for Walmart and JCPenney......»»

Category: topSource: moneycentralAug 16th, 2018

Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dyst.....»»

Category: smallbizSource: nytJun 20th, 2018

Deciphera Pharma Hit With Sell-Side Downgrade On Valuation After 50% Gain

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) lost a sell-side bull Tuesday, with a B. Riley FBR analyst praising the company's pipeline but concluding the biotech's positives are priced into the stock. Late.....»»

Category: blogSource: benzingaJun 19th, 2018

Pharma & Biotech ETFs Soar on Trump"s Drug Plan

Zacks.....»»

Category: topSource: redinewsMay 14th, 2018

Pharma & Biotech ETFs Soar on Trump"s Drug Plan

Trump's drug plan went in favor of pharma and biotech companies, which caused .....»»

Category: smallbizSource: nytMay 14th, 2018

Cannabis stocks rally with Aurora leading, after report that Coca-Cola has held talks on potential investment

Cannabis stocks rallied across the board on Monday, with Aurora Cannabis Inc. leading the charge, after a report that Coca-Cola Co. has be.....»»

Category: topSource: marketwatchSep 17th, 2018

This cancer-fighting biotech sped from startup to IPO filing in 10 months

The team that took Kite Pharma from a startup re-engineering a patient's own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie B.....»»

Category: topSource: bizjournalsSep 17th, 2018

Pharma/Biotech Stocks to Watch This Prostate Cancer Month

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

Leading the charge for startups

As the program continues to expand, the one leading the charge is Dawn Lippert, a Yale graduate and former Booz Allen Hamilton analyst turned accelerator CEO......»»

Category: topSource: bizjournalsSep 13th, 2018

5 Fixed-Income ETFs to Take Advantage of Extended Bull Market

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsSep 12th, 2018

3 Top Stocks for Investing in Pharma"s Next $35 Billion Market

Here's why these three biotechs could come out ahead in the race to tackle a leading cause of liver failure......»»

Category: topSource: foxnewsSep 12th, 2018

Goldman"s Specialty Pharma Pair Trade: Sidelined On Endo, Bearish On Mallinckrodt

The biotech sector has seen some year-to-date strength, as reflected by the nearly 11-percent advance in the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB). The upward momentum became more pronounced in late June. Latest Ratings for E.....»»

Category: blogSource: benzingaSep 11th, 2018

A Double Pair Trade: Morgan Stanley Buys 2 Biotechs, Sells 2 Others

Biotech plays are numerous, and Morgan Stanley has a few recommendations to pare and prop a pharma portfolio. The Ratings Analyst Jeffrey Hung initiated coverage of: Latest Ratings for ALDR DateFirmAction.....»»

Category: blogSource: benzingaSep 10th, 2018

Stifel pharma/biotech analyst to hold an analyst/industry conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2018

JPMorgan pharma and biotech analysts to hold analyst/industry conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2018

The Nasdaq 100 And Russell 2000 ETFs Are In Bull Market Territory, The Spiders ETF Is An "Inflating Parabolic Bubble"

The Nasdaq 100 And Russell 2000 ETFs Are In Bull Market Territory, The Spiders ETF Is An "Inflating Parabolic Bubble".....»»

Category: topSource: seekingalphaSep 5th, 2018

Biotech Analysis Central Pharma News: Pfizer Axes Drug, Merck"s Approvals, Bayer"s Green Light

Biotech Analysis Central Pharma News: Pfizer Axes Drug, Merck"s Approvals, Bayer"s Green Light.....»»

Category: topSource: seekingalphaSep 5th, 2018

Pharma veteran Jackie Fouse is leaving a SoftBank-backed biotech founded by a 33-year-old to run a cancer drugmaker

Courtesy Agios Pharma veteran Jackie Fouse.....»»

Category: topSource: businessinsiderSep 4th, 2018

Cowen biotech/pharma analysts to hold an analyst/industry conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 4th, 2018

JPMorgan Euro pharma & biotech analysts to hold analyst/industry conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 4th, 2018